1. Home
  2. STOK vs ALKT Comparison

STOK vs ALKT Comparison

Compare STOK & ALKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$30.79

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Alkami Technology Inc.

ALKT

Alkami Technology Inc.

HOLD

Current Price

$18.12

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
ALKT
Founded
2014
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
STOK
ALKT
Price
$30.79
$18.12
Analyst Decision
Strong Buy
Buy
Analyst Count
10
7
Target Price
$39.20
$28.57
AVG Volume (30 Days)
469.0K
1.6M
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
92.73
N/A
EPS
N/A
N/A
Revenue
$184,420,000.00
$152,159,000.00
Revenue This Year
N/A
$21.85
Revenue Next Year
$77.49
$16.90
P/E Ratio
N/A
N/A
Revenue Growth
404.50
35.68
52 Week Low
$9.47
$14.11
52 Week High
$40.22
$31.18

Technical Indicators

Market Signals
Indicator
STOK
ALKT
Relative Strength Index (RSI) 44.04 63.81
Support Level $30.34 $15.16
Resistance Level $35.11 $19.21
Average True Range (ATR) 1.49 0.79
MACD 0.10 0.11
Stochastic Oscillator 43.44 84.52

Price Performance

Historical Comparison
STOK
ALKT

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About ALKT Alkami Technology Inc.

Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.

Share on Social Networks: